PostPlacental IUD Insertion

Contraception Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02679820
• Other study ID #: LA010516
• Status: Completed
• Phase: N/A
• Start date: January 2016
• Est. completion date: December 2018

Study information

• Verified date: January 2019
• Source: Woman's Health University Hospital, Egypt
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The immediate post cesarean section IUD insertion is a further step towards spreading more compliance to females in developing countries, with rapid increase in population size

Recruitment information / eligibility

• Status: Completed
• Enrollment: 500
• Est. completion date: December 2018
• Est. primary completion date: December 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 45 Years

Eligibility

Inclusion Criteria:

• Females desiring contraception by using intrauterine device following their vaginal delivery or cesarean section

Exclusion Criteria:

• refusal to participate in the study

• desiring other methods of contraception

• will not use any method of contraception

• has a contraindication for the use of IUD as bicornuate or septate uterus, sub mucous myomas, etc.

Related Conditions & MeSH terms

• Contraception

Intervention

Device:
• Copper T intrauterine device

Locations

Country	Name	City	State
Egypt	Kasr el aini hospital	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Woman's Health University Hospital, Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Expulsion rate		6 months
Primary	The percentage of females seeking contraception		6 months